Merck
MRK
#47
Rank
S$418.25 B
Marketcap
S$169.35
Share price
0.52%
Change (1 day)
57.90%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): S$4.58

According to Merck's latest financial reports the company's current EPS (TTM) is S$4.62. In 2025 the company made an earnings per share (EPS) of S$9.44 an increase over its 2024 EPS that were of S$8.73.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$4.58-51.47%
2025S$9.448.15%
2024S$8.734308.46%
2023S$0.20-97.32%
2022S$7.4010.92%
2021S$6.6784.68%
2020S$3.61-27.2%
2019S$4.9663.44%
2018S$3.04151.11%
2017S$1.21-54.58%
2016S$2.6630.21%
2015S$2.04-61.99%
2014S$5.38180.51%
2013S$1.92-31.82%
2012S$2.816.62%
2011S$2.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.28 144.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.06 96.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$1.69-63.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$4.66 0.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$36.44 689.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.70 305.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$3.30-28.40%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$4.60-0.42%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$5.02 8.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$1.77-61.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel